Roivant (Nasdaq: ROIV), which completed its combination with Montes Archimedes in September 2021, announced this afternoon the fair market value in connection to redeeming its outstanding public and private warrants for $0.10 per warrant.
Holders may exercise the warrants until 5:00 p.m. EST on September 1, for an exercise price of $11.50 per share, payable in cash. But, if the holders decide to exercise their warrants on a cashless basis prior to the redemption date, then they will receive approximately 0.2495 common shares per warrant based on the fair market value of $11.35.
Following September 1, the warrants (NASDAQ:ROIVW) will cease trading and any that remain unexercised will be delisted and void.
The SPAC originally announced the redemption of all outstanding warrants on August 2. Under the terms of the warrant agreement, Roivant is entitled to redeem the warrants if the last reported sales price of the common shares is at least $10 per share for any 20 trading days within the 30 trading-day period ending on the third trading day prior to the date when a notice is given. And, if the reference value is less than $18 per share, the outstanding private placement warrants are also concurrently called for redemption on the same terms as the outstanding public warrants. This share price performance requirement was satisfied on July 28.
Montes Archimedes announced its $5 billion combination with Roivant in May 2021 and the parties completed the deal months later in September 2021. Basel, Switzerland-based Roivant develops an array of drug candidates acquired from peers or internally developed with its enhanced computing platform.
Athena Consumer Acquisition Corp. (NYSE:ACAQ) announced this afternoon that its stockholders approved its combination with German EV-maker e.GO at a special meeting held earlier today. Additionally, Athena Consumer’s warrant proposal to convert all outstanding warrants to 0.175 shares in the combined company was also approved. A total of 884,880 shares of Athena Class A Common...
October is set to be a quiet month for lock-up expirations with only four de-SPACs and four sponsors now open to trade their shares for the first time. The first customer is Bitdeer Technologies. Its shareholders and the Blue Safari sponsor both stand to gain the most out of this group from moving some of...
Graf Acquisition Corp. IV (NYSE:GFOR) announced in an 8-K this afternoon that its shareholders approved its combination with NKGen Biotech at a special meeting September 25. A total of 3,386,528 shares were redeemed in connection with the vote, leaving Graf IV with about $27.6 million in the tank and a final redemption rate of 84.3%....
Anzu Special Acquisition Corp I (NASDAQ:ANZU) has closed its combination with Envoy Medical and its shares and warrants are to begin trading on the Nasdaq under the symbols “COCH” and “COCHW” on October 2. The SPAC secured shareholder approval on September 27 and still has not divulged redemption figures. But, it went into the vote...
Mercato Partners (NASDAQ:MPRA) closed its combination with Brazilian software firm Nuvini this afternoon and its shares and warrants are expected to begin trading on the Nasdaq under the symbols “NVNI” and “NVNIW” on October 2. The combined company will continue to be led by its existing CEO and a seven-member Board including Mercato CEO Dr....